74 related articles for article (PubMed ID: 2150766)
1. Mixed lymphocyte culture reactivity of fetal baboons: application for in utero bone marrow transplantation.
Muirhead DY; Kuehl TJ; Vandeberg JL; Menchaca EM; Downs MP; Roodman GD
Bone Marrow Transplant; 1990 Oct; 6(4):263-7. PubMed ID: 2150766
[TBL] [Abstract][Full Text] [Related]
2. In utero bone marrow transplantation of fetal baboons with mismatched adult baboon marrow.
Roodman GD; Kuehl TJ; Vandeberg JL; Muirhead DY
Blood Cells; 1991; 17(2):367-75. PubMed ID: 1833000
[TBL] [Abstract][Full Text] [Related]
3. In utero bone marrow transplantation of fetal baboons with mismatched adult marrow: initial observations.
Roodman GD; Vandeberg JL; Kuehl TJ
Bone Marrow Transplant; 1988 Mar; 3(2):141-7. PubMed ID: 3048478
[TBL] [Abstract][Full Text] [Related]
4. Long-term engraftment following in utero T cell-depleted parental marrow transplantation into fetal rhesus monkeys.
Cowan MJ; Tarantal AF; Capper J; Harrison M; Garovoy M
Bone Marrow Transplant; 1996 Jun; 17(6):1157-65. PubMed ID: 8807129
[TBL] [Abstract][Full Text] [Related]
5. In utero hematopoietic stem cell transplants for inherited diseases.
Cowan MJ; Golbus M
Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):35-42. PubMed ID: 7906103
[TBL] [Abstract][Full Text] [Related]
6. Injection of allogeneic bone marrow cells into the portal vein of swine in utero.
Rubin JP; Cober SR; Butler PE; Randolph MA; Gazelle GS; Ierino FL; Sachs DH; Lee WP
J Surg Res; 2001 Feb; 95(2):188-94. PubMed ID: 11162044
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow transplantation from alpha1,3-galactosyltransferase gene-knockout pigs in baboons.
Tseng YL; Dor FJ; Kuwaki K; Ryan D; Wood J; Denaro M; Giovino M; Yamada K; Hawley R; Patience C; Schuurman HJ; Awwad M; Sachs DH; Cooper DK
Xenotransplantation; 2004 Jul; 11(4):361-70. PubMed ID: 15196131
[TBL] [Abstract][Full Text] [Related]
8. Nonspecific suppressor T cells cause decreased mixed lymphocyte culture reactivity in bone marrow transplant patients.
Harada M; Ueda M; Nakao S; Kondo K; Odaka K; Shiobara S; Matsue K; Mori T; Matsuda T
J Immunol; 1986 Jul; 137(2):428-32. PubMed ID: 2941480
[TBL] [Abstract][Full Text] [Related]
9. Unrelated donor matching for bone marrow transplantation.
Chopek M; Alosco S; Salazar M; Yunis EJ
Transplant Proc; 1993 Feb; 25(1 Pt 2):1255-8. PubMed ID: 8442106
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T cell activity after HLA-mismatch bone marrow transplantation.
Møller J; Dickmeiss E; Jacobsen N; Svejgaard A
Tokai J Exp Clin Med; 1996 Feb; 21(1):19-23. PubMed ID: 9239800
[TBL] [Abstract][Full Text] [Related]
11. Education of lymphocytes in vivo following a transient take of a matched unrelated bone-marrow graft in man.
Goldmann SF; Kristensen T; Grunnet N; Lohrmann HP; Heimpel H; Kissmeyer-Nielsen F
Clin Exp Immunol; 1977 Aug; 29(2):266-71. PubMed ID: 143356
[TBL] [Abstract][Full Text] [Related]
12. Stable multilineage chimerism across full MHC barriers without graft-versus-host disease following in utero bone marrow transplantation in pigs.
Lee PW; Cina RA; Randolph MA; Goodrich J; Rowland H; Arellano R; Kim HB; Sachs DH; Huang CA
Exp Hematol; 2005 Mar; 33(3):371-9. PubMed ID: 15730861
[TBL] [Abstract][Full Text] [Related]
13. Identification of unrelated HLA-identical bone marrow donors: RFLP, oligotyping and PCR fingerprinting for HLA class II compared to MLC responses.
Mazzola G; el-Borai MH; Berrino M; Cornaglia M; Amoroso A
Bone Marrow Transplant; 1993; 11 Suppl 1():24-7. PubMed ID: 8095414
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma-based mixed lymphocyte culture as a selection tool for allogeneic bone marrow donors other than identical siblings.
van der Meer A; Wissink WM; Schattenberg AV; Joosten I
Br J Haematol; 1999 May; 105(2):340-8. PubMed ID: 10233402
[TBL] [Abstract][Full Text] [Related]
15. Abnormal T-lymphocyte colonies (CFU-TL) following bone marrow transplantation.
Mitsuyasu RT; Li SN; Champlin RE; Gale RP
Exp Hematol; 1986 Dec; 14(11):1049-55. PubMed ID: 3536545
[TBL] [Abstract][Full Text] [Related]
16. [Significance and features of MLC reaction in histocompatibility determination of donor and recipient in allogenic bone marrow transplantation to patients with hematological malignancies].
Shpakova AP; Bulycheva TI; Liubimova LS; Mendeleeva LP
Ter Arkh; 2000; 72(11):62-7. PubMed ID: 11229316
[TBL] [Abstract][Full Text] [Related]
17. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
18. Engraftment rates related to busulphan and cyclophosphamide dosages for displacement bone marrow transplants in fifty children.
Hobbs JR; Hugh-Jones K; Shaw PJ; Downie CJ; Williamson S
Bone Marrow Transplant; 1986 Dec; 1(2):201-8. PubMed ID: 2971409
[TBL] [Abstract][Full Text] [Related]
19. Suppression of alloreactivity with gamma delta T-cells: relevance to increased gamma delta T-cells following bone marrow transplantation.
Nagai M; Azuma E; Qi J; Kumamoto T; Hiratake S; Hirayama M; Umemoto M; Komada Y; Sakurai M
Biomed Pharmacother; 1998; 52(3):137-42. PubMed ID: 9755807
[TBL] [Abstract][Full Text] [Related]
20. New strategies for selection of unrelated bone marrow donors.
Martinelli G; Buzzi M; Farabegoli P; Testoni N; Mantovani V; Calori E; Rosti G; Bandini G; Bragliani M; Panzica G
Bone Marrow Transplant; 1993; 11 Suppl 1():31-2. PubMed ID: 8448542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
